Cancer treatment systems maker BSD Medical Corp (BSDM) has secured 510 (k) approval from the U.S. Food and Drug Administration (FDA) for its MicroThermX Microwave Ablation System (MTX-180) for soft tissue ablation (destruction). With this approval, the company can now commercialize the innovative device in the U.S. BSD Medical’s shares jumped $1.84 (or 162.8%) following the news closing at $2.97 on August 18.
TEL AVIV, Israel, Aug. 9, 2010 (GLOBE NEWSWIRE) -- mBeach Software Inc. ("MBHS") (OTCBB:MBHS) today announced the start of regulatory procedures to market the company's advanced cancer diagnostic solution in Russia. This follows mBeach's recent announcement on the signing of an MOU for Russia and the Commonwealth of Independent States (CIS).
Completing these regulatory procedures will pave the way for local clinical trials and a full...
July 28 (Bloomberg) -- Dendreon Corp.’s prostate cancer vaccine, Provenge, extended lives by 4.1 months in a study published in the New England Journal of Medicine. The data, released previously, led to the drug’s U.S. approval in April.
Provenge is the first drug designed to train the body’s immune system to fight cancer and is the most effective treatment for certain patients with advanced prostate tumors, said Philip...
MediGene Earns €25M with Astellas' Purchase of Euro Rights to Marketed Prostate Cancer Drug
MediGene has sold full European marketing and distribution rights to its prostate cancer drug Eligard® to Astellas Pharma Europe for €25 million (about $31.6 million) plus royalties. Astellas partnered with MediGene in the latter’s European approval process for Eligard and has distributed the drug in Europe since 2004.
The Launch and Uptake of Nine Emerging Therapies Will Drive the Prostate Cancer Drug Market to More Than Double to $8.4 Billion in 2019
Emerging Therapies, Most Notably Dendreon's Provenge, Will Account For More Than Half of the Total Prostate Cancer Market in 2019, According to Findings from Decision Resources
WALTHAM, Mass., July 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds...
Blog Categories
Uncategorized
(1)
